Standard infant formula
Sponsors
Abbott Nutrition, Société des Produits Nestlé (SPN), Biostime, Inc., Ludwig-Maximilians - University of Munich, Laboratorios Ordesa
Conditions
GrowthHealthHealthyHealthy GrowthHealthy Term InfantImmune FunctionsImmunityInfant Development
Phase 2
Tolerance and Development of Healthy, Term Infants
CompletedNCT00465764
Start: 2007-04-30End: 2008-06-30Updated: 2009-04-27
A Clinical Study to Investigate the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth, Safety and Tolerance in Healthy Term Infants
CompletedNCT03062761
Start: 2017-04-27End: 2018-11-12Updated: 2019-01-14
Phase 3
A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy
WithdrawnNCT03062995
Start: 2019-06-30End: 2023-12-31Updated: 2021-12-23
A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy
CompletedNCT03067714
Start: 2017-03-30End: 2020-03-25Updated: 2021-12-08
Unknown Phase
Effect of the Level of Dietary Protein on Infant Growth
CompletedNCT00716105
Start: 2008-08-31End: 2015-02-28Updated: 2015-05-19
Effect of Formula on Growth of Infants From Overweight or Obese Mothers
CompletedNCT00820833
Start: 2007-10-31End: 2014-12-31Updated: 2015-03-26
Assessment of Growth of Infants Fed a New Formula
CompletedNCT00937014
Start: 2010-02-28End: 2013-06-30Updated: 2013-06-26
Effect of an Infant Formula on Infant Growth, Health and Immune Functions
NCT00970398
Start: 2009-09-30End: 2013-07-31Target: 320Updated: 2013-04-22
Formula With Modified Content of Protein and Improved Fatty Acids and Their Impact on Infant Growth and Health
CompletedNCT01094080
Start: 2010-02-28End: 2018-05-31Updated: 2020-09-02
A Neurocognitive and Immunological Study of a New Formula for Healthy Infants
NCT02094547
Start: 2010-12-31End: 2020-10-31Updated: 2019-07-12
Effects of Specific Lipid Fractions-enriched Infant Formulae
CompletedNCT02111837
Start: 2009-11-30End: 2010-12-31Updated: 2014-04-11
Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula
NCT02410057
Start: 2014-11-30End: 2024-12-31Updated: 2022-08-18
Nutritive Efficacy and Safety of a Modified Infant Formula With a Reduced Protein Content and Improved Protein Quality
CompletedNCT02469402
Start: 2014-01-31End: 2016-12-31Updated: 2020-06-09
Acceptability and Gastrointestinal Tolerance of a High-Sn-2 Infant Formula
CompletedNCT02598817
Start: 2018-07-01End: 2021-01-05Updated: 2023-02-24
Safety and Efficacy Study
CompletedNCT02670863
Start: 2016-01-21End: 2017-05-31Updated: 2021-10-11
Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease
CompletedNCT03456934
Start: 2017-08-07End: 2022-10-13Updated: 2023-03-17
Happy Smooth Study
CompletedNCT03710551
Start: 2018-09-26End: 2019-07-21Updated: 2021-02-21
Growth and Tolerance Trial on Infant Formula With HMO
TerminatedNCT04066413
Start: 2019-09-23End: 2023-01-26Updated: 2023-09-28
The Impact of a Novel Infant Formula on Immunity, Gut Health and Growth
Active, not recruitingNCT06686433
Start: 2025-01-13End: 2026-12-01Updated: 2026-03-17